![](/img/cover-not-exists.png)
PND36 10-YEAR COST-EFFECTIVENESS ANALYSES OF FREMANEZUMAB COMPARED TO NO TREATMENT AS A PREVENTIVE TREATMENT IN CHRONIC AND EPISODIC MIGRAINE FOR PATIENTS WITH INADEQUATE RESPONSE TO PRIOR PREVENTIVE TREATMENTS
Smolen, L., Gandhi, S.K., Klein, T., Thompson, S., Cohen, J.Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.1806
Date:
November, 2019
File:
PDF, 319 KB
2019